The company posted net earnings of $5.05 million, or $1.22 per share, up from $4.8 million, or $1.16 per share, during the same period last year. Revenue saw a sharper climb, reaching $62.7 million compared to $54 million in the previous year's second quarter.

Driving this growth was the January 15 acquisition of My Medic assets. While the integration contributed to top-line gains, the company noted that comparable sales rose 8% when excluding the new business. My Medic had a negligible effect on second-quarter earnings due to its seasonal structure; as a direct-to-consumer entity, the brand historically concentrates the majority of its profitability in the fourth quarter.